对共付额累积器的强烈反对。
Backlash Against Copay Accumulators.
作者信息
Silverman Ed
出版信息
Manag Care. 2018 Sep;27(9):15.
PMID:30216152
Abstract
With accumulators, the value of any copay assistance cards or coupons does not count toward out-of-pocket medicine costs that are applied toward deductibles. It's a cost-shifting tool that's facing pushback from patients, providers, and others saying that accumulators will hurt public health.
摘要
对于累加器而言，任何共付额援助卡或优惠券的价值都不计入用于抵扣免赔额的自付药品费用。这是一种成本转移工具，正面临患者、医疗服务提供者及其他人士的抵制，他们称累加器会损害公众健康。
相似文献
1
Backlash Against Copay Accumulators.对共付额累积器的强烈反对。
Manag Care. 2018 Sep;27(9):15.
2
EpiPen price backlash comes as consumers pay greater share.随着消费者承担更大份额的费用，肾上腺素笔引发了价格反弹。
Mod Healthc. 2016 Oct;46(35):12-13.
3
A primer on copay accumulators, copay maximizers, and alternative funding programs.关于共付额累积器、共付额最大化器及替代筹资计划的入门知识。
J Manag Care Spec Pharm. 2024 Aug;30(8):883-896. doi: 10.18553/jmcp.2024.30.8.883.
4
Copayments Not Counting Toward the Deductible Could Have Unintended Consequences.不计算在免赔额内的自付费用可能会产生意想不到的后果。
Manag Care. 2017 Dec;26(12):34-35.
5
The case against excessive cost sharing.反对过度成本分担的理由。
Am J Manag Care. 2006 Apr;12(6 Suppl):S162-4; discussion S167-72; quiz S173-6.
6
The effect of a copay increase on pharmaceutical utilization, expenditures, and treatment continuation.自付费用增加对药品使用、支出及治疗持续情况的影响。
Am J Manag Care. 1999 Nov;5(11):1383-94.
7
Effects of prescription coinsurance and income-based deductibles on net health plan spending for older users of inhaled medications.处方共付保险和基于收入的免赔额对老年吸入药物使用者健康保险计划净支出的影响。
Med Care. 2009 May;47(5):508-16. doi: 10.1097/MLR.0b013e318190d482.
8
Defined-contribution products and their influence on pharmacy benefit management.定额供款产品及其对药品福利管理的影响。
Manag Care Interface. 2003 Aug;16(8):36-8.
9
4 cost containment strategies that work.行之有效的4种成本控制策略。
Bus Health. 1993 Aug;11(9):38-40, 42.
10
Control of prescription costs--is it possible?控制处方药费用——这可行吗？
Empl Benefits J. 2002 Mar;27(1):11-4.
Zotero 插件